Johnson & JohnsonJohnson & JohnsonJohnson & Johnson

Johnson & Johnson

No trades
See on Supercharts

Key facts today

Johnson & Johnson's Q2 earnings beat forecasts with strong Pharma and MedTech sales, notably Darzalex and Stelara. Acquisitions prompt higher 2024 sales outlook but lower EPS prediction.
Johnson & Johnson's oncology sales rose 16% globally, fueled by Darzalex and Erleada, with new lung and bladder cancer treatments in development to boost sales further.
Stifel raised Johnson & Johnson's price target to $160 from $155, with analysts maintaining an average outperform rating and a price target range of $155 to $215.
Analyze the impactAnalyze the impact
Next report date
Report period
EPS estimate
Revenue estimate
Market capitalization
‪363.43 B‬USD
‪14.17 B‬USD
‪85.15 B‬USD
‪2.40 B‬
Beta (1Y)

About Johnson & Johnson

Joaquin Duato
New Brunswick
Employees (FY)
‪131.9 K‬
Johnson & Johnson is a holding company, which engages in the research and development, manufacture and sale of products in the health care field. It operates through the following segments: Consumer Health, Pharmaceutical, and Medical Devices. The Consumer Health segment includes products used in the baby care, oral care, beauty, over-the-counter pharmaceutical, women's health, and wound care markets. The Pharmaceutical segment focuses on therapeutic areas, such as immunology, infectious diseases, neuroscience, oncology, pulmonary hypertension, and cardiovascular & metabolic diseases. The Medical Devices segment offers products used in the orthopedic, surgery, cardiovascular & neurovascular, and eye health fields. The company was founded by Robert Wood Johnson I, James Wood Johnson and Edward Mead Johnson Sr. in 1886 and is headquartered in New Brunswick, NJ.
Revenue to profit conversion
Debt level and coverage

See all ideas 

Summarizing what the indicators are suggesting.
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of JNJ is 156.58 USD — it has increased by 3.69% in the past 24 hours. Watch Johnson & Johnson stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NYSE exchange Johnson & Johnson stocks are traded under the ticker JNJ.
JNJ stock has risen by 6.33% compared to the previous week, the month change is a 7.97% rise, over the last year Johnson & Johnson has showed a 1.57% decrease.
We've gathered analysts' opinions on Johnson & Johnson future price: according to them, JNJ price has a max estimate of 215.00 USD and a min estimate of 155.00 USD. Watch JNJ chart and read a more detailed Johnson & Johnson stock forecast: see what analysts think of Johnson & Johnson and suggest that you do with its stocks.
JNJ reached its all-time high on Apr 25, 2022 with the price of 186.69 USD, and its all-time low was 0.52 USD and was reached on Mar 14, 1968. View more price dynamics on JNJ chart.
See other stocks reaching their highest and lowest prices.
JNJ stock is 4.28% volatile and has beta coefficient of 0.48. Track Johnson & Johnson stock price on the chart and check out the list of the most volatile stocks — is Johnson & Johnson there?
Today Johnson & Johnson has the market capitalization of ‪376.84 B‬, it has increased by 2.01% over the last week.
Yes, you can track Johnson & Johnson financials in yearly and quarterly reports right on TradingView.
Johnson & Johnson is going to release the next earnings report on Oct 15, 2024. Keep track of upcoming events with our Earnings Calendar.
JNJ earnings for the last quarter are 2.82 USD per share, whereas the estimation was 2.71 USD resulting in a 4.01% surprise. The estimated earnings for the next quarter are 2.37 USD per share. See more details about Johnson & Johnson earnings.
Johnson & Johnson revenue for the last quarter amounts to ‪22.45 B‬ USD, despite the estimated figure of ‪22.33 B‬ USD. In the next quarter, revenue is expected to reach ‪22.17 B‬ USD.
JNJ net income for the last quarter is ‪3.26 B‬ USD, while the quarter before that showed ‪4.05 B‬ USD of net income which accounts for −19.61% change. Track more Johnson & Johnson financial stats to get the full picture.
Yes, JNJ dividends are paid quarterly. The last dividend per share was 1.24 USD. As of today, Dividend Yield (TTM)% is 3.07%. Tracking Johnson & Johnson dividends might help you take more informed decisions.
Johnson & Johnson dividend yield was 3.00% in 2023, and payout ratio reached 84.93%. The year before the numbers were 2.52% and 66.07% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Jul 18, 2024, the company has ‪131.90 K‬ employees. See our rating of the largest employees — is Johnson & Johnson on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Johnson & Johnson EBITDA is ‪30.43 B‬ USD, and current EBITDA margin is 34.82%. See more stats in Johnson & Johnson financial statements.
Like other stocks, JNJ shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Johnson & Johnson stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Johnson & Johnson technincal analysis shows the strong buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Johnson & Johnson stock shows the buy signal. See more of Johnson & Johnson technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.